Max Healthcare Institute Limited has informed the Exchange regarding allotment of Equity Shares under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022.
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Max Healthcare's Nomination & Remuneration Committee approved the allotment of 42,266 equity shares (face value ₹10) to eligible employees on March 17, 2026, following the exercise of vested stock options under the company's ESOP 2022 scheme. The exercise price was ₹350 per share, implying a premium of ₹340 over face value. With this allotment, the company's total paid-up equity share capital has increased from ₹973,09,27,750 (97,30,92,775 shares) to ₹973,13,50,410 (97,31,35,041 shares). The company has clarified that this allotment is not material in nature under SEBI LODR regulations. The newly issued shares are identical to existing equity shares and are in dematerialised form.
Minimal dilution impact since the 42,266 shares are a tiny fraction (about 0.004%) of the total share base. This is a routine ESOP exercise disclosure and is unlikely to have any meaningful effect on the stock price or shareholder value.